Inupadenant
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Inupadenant, covering 2024-09-19 to 2025-08-03. Get the full timeline:
Most recent: Clinical Trial Update: Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer [Phase 2]